{"database": "lobbying", "table": "lobbying_activities", "rows": [[2143288, "3ad05305-318d-46db-bf80-77f77fb9ef9a", "Q2", "KOUNTOUPES DENHAM CARR & REID, LLC", 320918, "CVS HEALTH", 2018, "second_quarter", "PHA", "General education about the pharmacy benefit manager/pharmacy industry, including S.637, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act.  Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.974 and H. R. 2212, The CREATES Act.  Proactive measures to curb opioid abuse, including H. R. 3528, Every Prescription Conveyed Securely Act, and H. R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,White House Office", 50000, null, 0, 0, "2018-07-12T16:45:54.800000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2143288"], "units": {}, "query_ms": 3.0795838683843613, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}